CANCER BUZZ interviews Doug Flora, MD about AI in Precision Oncology, the first- ever peer-reviewed journal on the topic.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Live this week from the ACCC 40th National Oncology Conference, CANCER BUZZ interviews Doug Flora, MD about AI in Precision Oncology, the first-ever peer-reviewed journal on the topic. The journal shares meaningful information on the evolution of these tools, especially for clinicians and decision makers to help make a case for artificial intelligence.
This program is part of the ACCC education program, Cancer Diagnostics. Thank you to our supporters, Amgen, AstraZeneca, Bristol Myers Squibb, Exact Sciences, Merck, and Eli Lilly and Company.
Doug Flora, MD
Editor-in-Chief, AI in Precision Oncology
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
